Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01415167 · ClinicalTrials.gov registry record
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
A clinical trial, sponsored by Prometheus Laboratories.
- Completed
- Registry status
- 1,690
- Enrollment target
NCT01415167: Completed study, sponsored by Prometheus Laboratories.
NCT01415167 is a clinical trial that has completed, run by Prometheus Laboratories. The registered enrollment target is 1,690 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01415167 has completed, sponsored by Prometheus Laboratories.
- COMPLETED
- Registry status
- 1,690 participants
- Enrollment target
Study Summary
The purpose of this registry is to collect information on patients who are receiving treatment with Proleukin in an organized way, and to learn more about patient care during and after treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,690 participants |
| Start Date | 2011-08 |
| Est. Completion | 2018-05 |
What the finished NCT01415167 record still lists
NCT01415167 is an observational study that tracks outcomes without assigning an intervention. Its 1,690 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01415167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01415167 about?
NCT01415167 is a clinical study titled "PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy". The purpose of this registry is to collect information on patients who are receiving treatment with Proleukin in an organized way, and to learn more about patient care during and after treatment.
What is the current status of trial NCT01415167?
This trial is currently completed. The enrollment target is 1,690 participants. The study started on 2011-08. Estimated completion is 2018-05.
Who is sponsoring clinical trial NCT01415167?
This trial is sponsored by Prometheus Laboratories, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia